PATENT CLAIM ANALYSIS

Application Number: 15907432
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["544", "405000"]

Abstract:
The present invention relates to compounds of formula (I) wherein R 1 , R 2 , and Z −  have one of the meanings as indicated in the specification or a pharmaceutically acceptable salt thereof, to the use of compounds of formula (I) as a medicament, to pharmaceutical composition comprising at least one compound of formula (I), as well as to medicament combinations containing one or more compounds of formula (I).

Claim (Index 6):
The method according to  claim 1 , wherein the disease is selected from among chronic bronchitis, acute bronchitis, bronchitis caused by bacterial or viral infection or fungi or helminths, allergic bronchitis, toxic bronchitis, chronic obstructive pulmonary disease (COPD), asthma, paediatric asthma, bronchiectasis, allergic alveolitis, allergic or non-allergic rhinitis, chronic sinusitis, idiopathic pulmonary fibrosis, cystic fibrosis or mucoviscidosis, alpha-1-antitrypsin deficiency, cough, pulmonary emphysema, interstitial lung diseases, alveolitis, hyperreactive airways, nasal polyps, pulmonary oedema and pneumonitis of different origins, and dry eyes.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 88.0
- Lexical Diversity: 1.80435
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15654301', '15542908', '15542896', '15542894', '15241146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7390757408926527
- 35 USC 102 Novelty (BERT): 0.4708681193329145
- Combined Prediction Score: 0.7122549787366789
- Mean Citation Score: 191.49208
- Max Citation Score: 195.71094
- Similarity Product: 168.8906390652895

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test